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In 1905, Dale showed in a series of classical experiments
that pretreatment with ergot not only abolished the pressor
action of adrenaline but also reversed it, producing a
depressor effect.'" Thus he was the first to show that the
catechol amines (adrenaline and noradrenaline) act on at
least 2 types of receptors. The findings that adrenaline and
noradrenaline, though chemically very similar, produce
qualitatively different effects on some tissues can only be
interpreted in this way as well.'" The receptors on which
adrenergic drugs act, were named the alpha and beta
receptors by AhJquist in 1948.3 Recent research has pro-
vided drugs which will selectively prevent the action of
the catechol amines on either the alpha or the beta
receptors.'
In this article the effect of adrenergic drugs on the
cardiovascular system and the modifying effect of blocking
agents will be discussed, while mention will be made of
receptors present in other body tissues. Finally, recent
research into the basic mechanism of action of adrenergic
drugs will be referred to.
THE EfFECT OF CATECHOL AMI rES ON THE
CARDIOVASCULAR SYSTEM
A. In The Normal Animal
Noradrenaline is a net vasoconstrictor; consequently,
the total peripheral resistance (TPR) is increased. Noradre-
naline also increases the contractile force of the heart. The
systolic blood pressure is raised owing to the increase in
TPR and in cardiac contractility. The rise in diastolic
pressure results from the increased TPR. In the intact
animal, the raised mean blood pressure causes a reflexly
induced increase in vagal tone with resultant bradycardia.'"
Adrenaline produces vasodilatation in skeletal muscle
blood-vessels and thus the TPR falls. The cardiac output
and pulse rate increase. The rise in systolic pressure pro-
duced results from the increase in cardiac output. Because
of the reduced TPR, there is a slight fall in the diastolic
blood pressure.":
Blood-vessels have 2 receptors for adrenergic drugs,":'"
Firstly these are the alpha constrictor receptors which
respond to noradrenaline. Secondly there are beta dilator
receptors which respond to isoprenaline. Adrenaline stimu-
lates both strongly. Alpha constrictor receptors are widely
distributed, but are lacking in the cardiac and cerebral
vascular beds." Beta receptors are most active in skeletal
muscle blood-vessels.'"
When adrenergic drugs act on the heart directly, they
are acting on the beta receptors only.'"
The observed effects of adrenaline and noradrenaline on
the cardiovascular system (see above) can be explained by
ilssuming that adrenaline acts on both alpha and beta
receptors.'" whereas noradrenaline acts primarily on alpha
receptors.'" but has. in addition. potent beta actions on the
heart.' Thus adrenaline produces vasodilatation in skeletal
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muscle, while elsewhere in the body, with the exception of
the coronary vessels, both adrenaline and noradrenaline
produce vasoconstriction." The actions of adrenaline and
noradrenaline on the isolated heart are qualitatively and
quantitatively similar.'
B. After The AdminisTration of Adrenergic Blocking
AgenTs
The adrenergic blocking agents may be divided into 2
groups, viz.:
I. Those That block The alpha recepTOrs. Examples of
such drugs are the ergot alkaloids, phenoxybenzamine,
phentolamine, dibenamine and chlorpromazine."-,,,1,. Pre-
treatment with these drugs produces progressive blockade
of the vasoconstrictor actions of adrenaline and noradrena-
line. This leads to a reversal of the pressor action of
adrenaline (as a result of its unopposed action on the beta
receptors) and abolition of that of noradrenaline.'" There
is no antagonism of the direct effects of either adrenaline
or noradrenaline on the heart.'"
2. Those That block The beta receptors. Examples of
such drugs are pronethanol,'o Inderal" and dichloroisopre-
naline." These drugs do not block the vasopressor effect
of either adrenaline or noradrenaline but antagonize the
cardiac actions of both amines and the vasodilatation of
adrenaline.' Thus the administration of adrenaline now
produces a rise in both systolic and diastolic blood pressure
with bradycardia."
It should be noted that many of these blocking agents
have important actions of their own in addition to block-
ade of responses to adrenaline and noradrenaline,'
THE CLASSIFICATION OF ADRENERGIC RECEPTORS
IN OTHER TISSUES
The general effects of adrenaline and noradrenaline have
been well reviewed elsewhere.""'" The receptors for the
various organs, etc., have been c!assified by several authors.
3._, •. ',"".," The following classification is based on the above
references, namely.
(a) Alpha recepTOrs. Vascular smooth muscle, pilomotor
muscle, the radial fibres of the iris;
(b) BeTa receptors. Vascular smooth muscle (in skeletal
muscle), myometrial muscle, cardiac muscle, bron-
chial mmcle; and
(c) BOTh alpha and beTa receptors. Intestinal smooth
muscle.
There has not been universal agreement on the classifi-
cation of certain effects of the catechol amines, particularly
their metabolic effects." A recent article by VoIle reviews
research which does not easily accord with traditional
classifications."
THE PHYSIOLOGICAL BASIS FOR THE EFFECTS
OF THE CATECHOL AMINES
Adrenaline promotes the formation of a cyclic nucleotide.
adenosine-3,5-phosphate. The cyclic nucleotide formed
stimulates the formation of active phosphorylase which
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Dr. H. Caplin reported: 'An anencephalic monster of most
unusual type. The "head" is partly macerated, extremely small
and so grossly distorted as to make it impossible to determine
the landmarks with any degree of certainty (Fig. I). There is
no mouth or nose, the ears being fused together in the
anterior midline; the right eye and orbit are just definable but
the vault is open with soft red granular tissue projecting
through It and the flat membrane bones (?parietal, ?occipital)
are incompletely fused posteriorly.'
Internal examination. 'Neither tongue nor epiglottis can be
identified. Thyroid and hyoid bones not found. Lower part of
trachea and main bronchi normal. Lungs airless, Oesophagus
and stomach normal. Heart normal except for patent foramen
ovale and ductus arteriosus. Intestines normal.'
X-ray examillalion (Fig. 2). Postmortem radiographs of the
child show that the general skeletal structure is essentially
normaL The skull, however, shows marked abnormality. The
medial growth of the mandible appears to have been arrested
at an early stage and maxillary and nasal bones are absent so
that the sphenoid and petrous temporal bones are well s~en.
There is evidence of ossification of the medial wall of the right
monster which forms the basis of this report. Immediately
after delivery the apex beat was palpable and the infant was
observed to make inspiratory movements of the chest After
2 minutes the heart stopped. Birth-weight was 1 kg. and the
length 40 cm.
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tween catechol amines, blocking agents and adrenergic
receptors."":S
SUMMARY
The effects of adrenaline and noradrenaline on tissues and
their possible relationship to receptors, are discussed. The
modifying effect of adrenergic blocking agents are outlined.
Theories concerning the basic action of the catechol amines
are presented.
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Anencephaly is the commonest foetal abnormality incom-
patible with survival, and the incidence has been given as
0·23% of all births.' Cyclopia in association with anence-
phaly is fairly common but association with aprosopia-
failure of development of facial structures-appears to be
rare enough to warrant the recording of the following case.
Case Report
I.M., a 19-year-old White housewife, a primagravida, was
first seen when 28-weeks pregnant. She had first felt foetal
movements 4 weeks before. Her height was 168·75 cm; she
weighed 66 kg. and her Hb. was 8·2 G/l00 m\. Her blood
pressure was 100/70 mm.Hg. The urine, serological tests and
chest X-ray examination were normal and she appeared to be
in good health.
She was next seen 4 weeks later when the urine and blood
pressure were again normal, but her weight had increased by
3·5 kg. and the height of the uterine fundus was greater than
that expected for the estimated period of gestation. There was
evidence of slight hydramnios.
Twelve days later the patient was admitted to hospital in
labour. The uterus was enlarged to the level of the xiphister-
num and there was marked hydramnios. A normal first stage
was followed by the rapid delivery of the anencephalic
then in turn stimulates glycogenlysis. Thus, when activated
in liver, an end-product is glucose, while lactate is formed
by skeletal muscle. There is some correlation between the
phosphorylase concentration in the heart and the effects of
the catechol amines on cardiac contractility. This would
suggest that the beta receptors for cardiac contractility are
very similar to, or identical with, those for the formation
of the cyclic nucleotide. 1S A 'cyclase system' may be the
actual beta receptor, involving cyclase, magnesium ions
and ATP.'· There is no evidence that the vascular alpha
receptors have anything to do with the formation of the
cyclic nucleotide.1S It has also been claimed that the
inhibition of plain muscle is due to the accumulation of
lactic acid,'" but not all authors agree with this theory."
Recent advances in the methods used for measuring the
electrophysical changes of muscle have also provided more
evidence about the action of the catechol amines. Studies
have suggested that adrenaline causes relaxation, secon-
dary to metabolic changes. Relaxation may be due to an
increase in the amount of energy available for the sodium
pump. Adrenaline has also a direct effect causing depola-
rization and thus contraction. The action in any situation
is thus the net result of these two actions. When the trans-
membrane potential is high, the direct depolarizing action
will predominate causing contraction. When the trans-
membrane potential is low, adrenaline will cause a rise in
potential and thus relaxation.""'" However, the above
explanation has been contested."
There has also been much research performed on the
biochemical, structural and functional relationships be-
